Carnitine-ODAN Tablets
Natural health product licensed in Canada
- Licence holder
- Odan Laboratories Ltd.
- NPN or DIN-HM
- 80043476
- Status
- Active licence
- Licence date
- 10 July 2013
- Revision date
- Not provided
- Form
- Comprimé
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Not provided.
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 6 Comprimé | minimum: 1 day ; maximum: 2 days |
| Adultes | minimum: 18 years | 3 Comprimé | 3 days |
| Adultes | minimum: 18 years | minimum: 3 Comprimé ; maximum: 6 Comprimé | minimum: 1 day ; maximum: 2 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Aids in the muscle recovery process by reducing muscle tissue damage associated with a resistance training regimen. Helps support muscle tissue repair in individuals involved in resistance training. Helps support fat metabolism. Helps support fat oxidation. Antioxidant.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80043476
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
No ingredient list for this product yet. Have it to hand? Photograph the ingredient list. Photograph the packaging